Rheumatoid arthritis drug tocilizumab falls short as treatment for hospitalized Covid-19 patients in three studies

Tocilizumab, a repurposed rheumatoid arthritis drug once considered a promising treatment for hospitalized patients with Covid-19, generally did not increase patients’ chances of survival or help them get better faster, according to three trials published this week.